During the COVID-19 pandemic the public were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.

Learn more

Drug development is an expensive and time-consuming process. On average, it costs $319.3 million for initial research and development and can take over eight years before a drug reaches the market. Additionally, 86.2% of all trials fail to reach market approval.

Learn more

For World Patient Safety Day in 2022, our Global Clinical Director Peter Kirpalani-Collins explains how digital healthcare tools can help keep patients safe by monitoring their symptoms and medication use.

Learn more

Patient safety may be paramount across healthcare, but we are a long way from ‘first, do no harm’. The World Health Organisation (WHO) reports that medication errors cause US$ 42 billion of global total health expenditure worldwide, 50% of the overall preventable harm in medical care.

Learn more

Our Global Clinical Directors Arrash Yassaee and Peter Kirpalani-Collins explain the importance of clinical rigour and evidence generation in digital health and how we’re doing things differently here at Huma.

Learn more

One of the first peer-reviewed assessments of a fully decentralized clinical trial (DCT) saw rapid recruitment (94% in 12 days), high engagement and that patients with low baseline increased their medication adherence.

Learn more